HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION

Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer'...

Full description

Saved in:
Bibliographic Details
Main Authors DIAMANITIS, GEORGE, MOORE, WILLIAM JAY, STOCK, JOSEPH RAYMOND, KREFT, ANTHONY FRANK, WOLLER, KEVIN ROGER, CASEBIER, DAVID SCOTT, COLE, DEREK CECIL, KURBRAK, DENNIS MICHAEL, KUTTERER, KRISTINA MARTHA
Format Patent
LanguageGerman
Published 11.01.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's disease and Down's syndrome are described.
AbstractList Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's disease and Down's syndrome are described.
Author COLE, DEREK CECIL
KURBRAK, DENNIS MICHAEL
WOLLER, KEVIN ROGER
STOCK, JOSEPH RAYMOND
KUTTERER, KRISTINA MARTHA
DIAMANITIS, GEORGE
CASEBIER, DAVID SCOTT
MOORE, WILLIAM JAY
KREFT, ANTHONY FRANK
Author_xml – fullname: DIAMANITIS, GEORGE
– fullname: MOORE, WILLIAM JAY
– fullname: STOCK, JOSEPH RAYMOND
– fullname: KREFT, ANTHONY FRANK
– fullname: WOLLER, KEVIN ROGER
– fullname: CASEBIER, DAVID SCOTT
– fullname: COLE, DEREK CECIL
– fullname: KURBRAK, DENNIS MICHAEL
– fullname: KUTTERER, KRISTINA MARTHA
BookMark eNqNyrsOgyAUAFCGdujrH0h3E8XEHeFaborQwHVwMqahU4Mm9v_TpR_Q6SznyHZ5yenAbgYIglejshiVAR4H23kne9TApY0cncEWyQdwXEPgLZAsZD9aj7p4BK-HO6F3Z7Z_ze8tXX6e2LUDUqZI6zKlbZ2fKafPpKEpK1GVtSAS9V_pC4TGL00
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DE60121032TT2
GroupedDBID EVB
ID FETCH-epo_espacenet_DE60121032TT23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:00:56 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DE60121032TT23
Notes Application Number: DE20016021032T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070111&DB=EPODOC&CC=DE&NR=60121032T2
ParticipantIDs epo_espacenet_DE60121032TT2
PublicationCentury 2000
PublicationDate 20070111
PublicationDateYYYYMMDD 2007-01-11
PublicationDate_xml – month: 01
  year: 2007
  text: 20070111
  day: 11
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies ARQULE INC
WYETH
RelatedCompanies_xml – name: ARQULE INC
– name: WYETH
Score 2.6630943
Snippet Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070111&DB=EPODOC&locale=&CC=DE&NR=60121032T2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1RT8IwEG4IGvVNUaOiZjFmb43QAWMPi9nazk23lYxh4MlQ1iX6AERm_Pu2FdAn3po2uVyb3N3Xa-87AO6nmqEEFbCw-zPY4aUD-awUcNpyCqfslojr34RJ2gtHnedxd1wDH5taGM0T-q3JEaVFzaS9V9pfL_-SWET_rVw98Hc5tXgMcpeYm9uxrVqnm8R36YARhk2MXULNNHN7irusZaFcuus9CaNtZQ301VdVKcv_ISU4BvsDKW1enYBaIRrgEG86rzXAQbJ-8JbDte2tTsFTSCX0ZHiC42iIQ2oMR3HAUi-JCDW8eGhEaRj5Uc4ymhqEZoZPcw96ySRmEYGDjJHRi8pHnYG7gOY4hFKjt-323wjdKp8j6xzU54u5uACGbZUKn6GWhDgdoWhtyr7F-45AvJgiYV2C5g5BVztXm-DoN4nZhu32NahXn1_iRkbfit_qY_sBw6mCjg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4QNOKbokbFH4sxe2uEDhh7WMzWdm6yrWQMA0-EsS3RByAy479vVwF94q1pk8u1yd19vfa-A3icSYYSnKJU781RO8kNlMzzDM2aRmrknRwn8jdhEHbdUft13BlX4GNbCyN5Qr8lOaKwqLmw90L669VfEovKv5Xrp-RdTC2fndik6vZ2rJet01Vqm2zAKScqISZlahiZ3ZK7rKnhWLjrAwGx9dIa2JtdVqWs_ocU5wQOB0LaojiFSprVoUa2ndfqcBRsHrzFcGN76zN4cZmAnpxMiO8NicuU4ch3eGgFHmWK5Q8VL3Q924t5xEKFskixWWwhK5j43KNoEHE66pf5qHN4cFhMXCQ0mu62P6Vsp3yMtQuoLpaL7BIUXctLfIabAuK0s5LWJu9pSc_IcJLOcKZdQWOPoOu9q_dQc-PAn_pe2G_A8W9Cs4VarRuoFp9f2a2IxEVyJ4_wBw9nhYE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROCYCLISCHE+SULFONAMIDE+ALS+INHIBITOREN+DER+BETA-AMYLOID-PRODUKTION&rft.inventor=DIAMANITIS%2C+GEORGE&rft.inventor=MOORE%2C+WILLIAM+JAY&rft.inventor=STOCK%2C+JOSEPH+RAYMOND&rft.inventor=KREFT%2C+ANTHONY+FRANK&rft.inventor=WOLLER%2C+KEVIN+ROGER&rft.inventor=CASEBIER%2C+DAVID+SCOTT&rft.inventor=COLE%2C+DEREK+CECIL&rft.inventor=KURBRAK%2C+DENNIS+MICHAEL&rft.inventor=KUTTERER%2C+KRISTINA+MARTHA&rft.date=2007-01-11&rft.externalDBID=T2&rft.externalDocID=DE60121032TT2